Prior government service disclosed in an LDA filing; exact dates not reported
Former United States Senator
Federal government
Inspect source ↗Sourced institutional rolesLDA lobbying records
THOMAS DASCHLE
THOMAS DASCHLE appears as a registered lobbyist in federal Lobbying Disclosure Act records connected to organizations tracked by Paper Trail.
Data updated Nov 1, 2026
Source-backed chronology
Career Timeline
Prior government service disclosed in an LDA filing; exact dates not reported
Former U.S. Senator
Federal government
Inspect source ↗Documented in an LDA filing dated Apr 20, 2018
Registered lobbyist
Inspect source ↗Prior government service disclosed in an LDA filing; exact dates not reported
Former Senator
Federal government
Inspect source ↗Federal LDA filings
Lobbying Activity
CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2018
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Drug pricing and transparency solutions.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2021
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
Policy and reimbursement changes to the MA program
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2023
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
Issues related to program cuts
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2021
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Issues related to COVID-19 testing, and health care coverage; COVID-19 emergency response, in general; drug pricing, in general; home and community-based services, in general; H.R.5376 - Build Back Better Act - provisions related to health care coverage, drug pricing, and taxation; issues related to the 340B program and clinical trials.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2021
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Budget/Appropriations
S.Con.Res.5 - A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; H.Res.101 - Providing for the adoption of the concurrent resolution (S. Con. Res. 5) setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; H.Con.Res.11 - Establishing the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030 - provisions related to health care coverage, drug pricing, and taxation.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2018
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Drug pricing policy.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2019
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
S.1895, Lower Health Care Costs Act, provisions related to pharmacy benefit managers.
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2020
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Availability of home dialysis, generally; surprise billing, generally; S.1895 - Lower Health Care Costs Act, provisions related to surprise billing; interoperability, generally; provisions related to health care coverage and COVID-19 testing, generally.
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2022
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Issues related to COVID-19 testing and health care coverage; COVID-19 emergency response, in general; drug pricing, in general; home and community-based services, in general; H.R.5376 - Build Back Better Act - provisions related to health care coverage, drug pricing, and taxation; issues related to the 340B program and clinical trials; H.R.7213 - Equitable Community Access to Pharmacist Services Act; S.4293 - Pharmacy Benefit Manager Transparency Act of 2022
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2022
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
H.R.7213 - Equitable Community Access to Pharmacist Services Act; S.4293 - Pharmacy Benefit Manager Transparency Act of 2022; H.R.5376 - Inflation Reduction Act of 2022, generally
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2022
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
Policy and reimbursement changes to the MA program
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2023
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Drug pricing proposals, generally; behavioral and mental health, generally; PBM oversight, generally; maternal health, generally
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2023
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Drug pricing proposals, generally; behavioral and mental health, generally; PBM oversight, generally; maternal health, generally
LDA filing ↗